PNPLA3 and metabolic dysfunction-associated steatotic liver disease: The eGFR values were significantly lower in the subjects with the PNPLA3 G/G genotype than in those with the C/C genotype among the non-NAFLD subjects [adjusted B (SE): -5.55 (1.96), P < 0.01], although no such association was observed between the PNPLA3 genotype and the eGFR values among the NAFLD subjects [adjusted B (SE): 2.40 (4.23), P = 0.57].